Skip to main content

Advertisement

SpringerLink
Log in

Focal Breast Microcalcifications: The Only Finding in a Patient with Extensive Breast Malignancy-Induced Paraneoplastic Syndrome

  • Case report
  • Published:
Indian Journal of Gynecologic Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

References

  1. Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med. 1991;325(21):1487–98.

    Article  CAS  PubMed  Google Scholar 

  2. Iaccarino L, Ghirardello A, Bettio S, Zen M, Gatto M, Punzi L, Doria A. The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun. 2014;1(48):122–7.

    Article  Google Scholar 

  3. Callen JP, Hyla JF, Bole GG, Kay DR. The relationship of dermatomyositis and polymyositis to internal malignancy. Arch Dermatol. 1980;116(3):295–8.

    Article  CAS  PubMed  Google Scholar 

  4. Marzęcka M, Niemczyk A, Rudnicka L. Autoantibody markers of increased risk of malignancy in patients with dermatomyositis. Clin Rev Allergy Immunol. 2022;63(2):289–96.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Oldroyd A, Sergeant JC, New P, McHugh NJ, Betteridge Z, Lamb JA, Ollier WE, Cooper RG, Chinoy H. The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis. Rheumatology. 2019;58(4):650–5.

    Article  PubMed  Google Scholar 

  6. Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O’Hanlon TP, Miller FW, Rider LG. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum: Off J Am Coll Rheumatol. 2006;54(11):3682–9.

    Article  CAS  Google Scholar 

  7. Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis. 2007;66(10):1345–9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Trallero-Araguás E, Labrador-Horrillo M, Selva-O’Callaghan A, Martínez MA, Martínez-Gómez X, Palou E, Rodriguez-Sanchez JL, Vilardell-Tarrés M. Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine. 2010;89(1):47–52.

    Article  PubMed  Google Scholar 

  9. Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura K, Matsushita T, Orito H, Hamaguchi Y, Yanaba K, Itoh M. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology. 2007;46(1):25–8.

    Article  CAS  PubMed  Google Scholar 

  10. Hida A, Yamashita T, Hosono Y, Inoue M, Kaida K, Kadoya M, Miwa Y, Yajima N, Maezawa R, Arai S, Kurasawa K. Anti-TIF1-γ antibody and cancer-associated myositis: a clinicohistopathologic study. Neurology. 2016;87(3):299–308.

    Article  CAS  PubMed  Google Scholar 

  11. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96–100.

    Article  CAS  PubMed  Google Scholar 

  12. Barnes BE. Dermatomyositis and malignancy: a review of the literature. Ann Intern Med. 1976;84(1):68–76.

    Article  CAS  PubMed  Google Scholar 

  13. Kankeleit H. Über primäre nichteitrige polymyositis. Dtsch Arch Klin Med. 1916;120(335):9.

    Google Scholar 

  14. Kubeček O, Soukup T, Paulík A, Kopecký J. Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report. BMC Cancer. 2016;16(1):1–7.

    Article  Google Scholar 

  15. Racanelli V, Prete M, Minoia C, Favoino E, Perosa F. Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev. 2008;7(5):352–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rajagiri Hospital, Aluva, Kochi, India

    Teena Sleeba, Priyanka Venkatesh, Jithin Antony & Preethy Harrison

Authors
  1. Teena Sleeba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priyanka Venkatesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jithin Antony
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Preethy Harrison
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Teena Sleeba.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sleeba, T., Venkatesh, P., Antony, J. et al. Focal Breast Microcalcifications: The Only Finding in a Patient with Extensive Breast Malignancy-Induced Paraneoplastic Syndrome. Indian J Gynecol Oncolog 22, 59 (2024). https://doi.org/10.1007/s40944-024-00802-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40944-024-00802-3

Keywords

Search

Navigation